Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
<strong>Background<br></strong> UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to...
Autori principali: | Bedston, S, Almaghrabi, F, Patterson, L, Agrawal, U, Woolford, L, Anand, SN, Joy, M, Crawford, A, Goudie, R, Byford, R, Abbasizanjani, H, Smith, D, Laidlaw, L, Akbari, A, Sullivan, C, Bradley, DT, Lyons, RA, de Lusignan, S, Hobbs, FDR, Robertson, C, Sheikh, SA, Shi, T |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Elsevier
2023
|
Documenti analoghi
Documenti analoghi
-
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context
di: Stuart Bedston, et al.
Pubblicazione: (2024-02-01) -
Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
di: Ward, IL, et al.
Pubblicazione: (2024) -
Waning of first and second dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
di: Kerr, S, et al.
Pubblicazione: (2022) -
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
di: Agrawal, U, et al.
Pubblicazione: (2022) -
Clinical coding of long Covid in Wales: A cohort study of 3.5 million people using linked health and demographic data
di: Hoda Abbasizanjani, et al.
Pubblicazione: (2023-09-01)